New Development on the FDA's NDI

Jarrow calls for Congressional hearings to address NDI guidance woes

June 19, 2012

Jarrow Formulas has raised its concerns about the FDA’s draft guidance on new dietary ingredients (NDIs) with House Speaker John Boehner as part of its campaign to alert members of Congress to the dangers the “fatally flawed” document presents to the supplements trade.

http://www.nutraingredients-usa.com/Regulation/Jarrow-calls-for-Congressional-hearings-to-address-NDI-guidance-woes